Security file · CUSIP N62509109
NEWAMSTERDAM PHARMA COMPANY
NEWAMSTERDAM PHARMA COMPANY · held by 2 tracked managers in Q2 2026.
Tracked holders · Q2 2026
2
+0 vs Q1 2026
Aggregate reported value
$253M
sum of holders' reported positions
New holders this quarter
0
1 added · 0 trimmed
Holder return since filing
—
weighted by each holder's position share · since filing
Ownership · Q2 2026
| Manager | Weight | Shares | Δ shares | Entry | Return | Value | Activity | |
|---|---|---|---|---|---|---|---|---|
| 1 | Viking Global Investorsfiled 14 Aug ET | 0.41% | 4.20M | +0.0% | — | — | $142M | Held |
| 2 | Lee Ainslie - Maverick Capitalfiled 14 Aug ET | 0.98% | 3.27M | +49.5% | — | — | $111M | Added |
Holder count
Aggregate reported value
Quarterly aggregation
| Quarter | Holders | Δ holders | Aggregate value | Total shares |
|---|---|---|---|---|
| Q2 2026 | 2 | +0 | $253M | 7.47M |
| Q1 2026 | 2 | +0 | $205M | 6.39M |
| Q4 2025 | 2 | +0 | $214M | 6.10M |
| Q3 2025 | 2 | +0 | $227M | 7.98M |
| Q2 2025 | 2 | +0 | $154M | 8.51M |
| Q1 2025 | 2 | +0 | $154M | 7.53M |
| Q4 2024 | 2 | +1 | $188M | 7.33M |
| Q3 2024 | 1 | — | $133M | 8.02M |